Telaah bibliometrik pola penyebaran pengetahuan tentang COVID-19 di dunia

2020 ◽  
Vol 25 (2) ◽  
pp. 33-38
Author(s):  
Dasapta Irawan ◽  
◽  
Astadi Pangarso ◽  
Ilham Ridlo ◽  
Anis Fuad ◽  
...  

The COVID-19 pandemic is a human tragedy of this century. All countries in the world are racing against time to fight the spread and deadly effects of this virus. This paper is a short meta analysis (short/rapid communications) literature review of COVID-19 / NCOV / Corona Virus in the Scopus, Dimensions, Lens, and Europe PMC database. We aim to find out the profile of publications about Corona Virus in the world, and do a short assessment using the prin-ciples of open access in knowledge distribution. The method used is literature review using commercial and non-commercial databases which are then visualized using simple spreadsheets software. The results of this study indicate that non-commercial databases also need to be used by researchers because they contain a much larger number of documents than major commercial databases. The majority of publications are peer reviewed articles in prestige journals (indicated by a high JIF). Gold OA and hybrid journals are generally chosen although the cost of publication (APC) is very expensive (up to USD 5000). The next option would be a non-OA association journal (eg: JAMA). The research itself was carried out by a small number of countries: Asia (China, Japan, India), the US, Europe (UK and Ger-many), and Saudi Arabia. When linked to the urgency of a pandemic disaster, COVID-19 research, especially those carried out in under-represented countries, needs to maximize the publicity via public repositories (Green OA route) under supervision of research commu-nities to jointly review and test the validity. Publication via journal can be done as a later step.

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Diego A. Forero ◽  
Walter H. Curioso ◽  
George P. Patrinos

AbstractThere has been an important global interest in Open Science, which include open data and methods, in addition to open access publications. It has been proposed that public availability of raw data increases the value and the possibility of confirmation of scientific findings, in addition to the potential of reducing research waste. Availability of raw data in open repositories facilitates the adequate development of meta-analysis and the cumulative evaluation of evidence for specific topics. In this commentary, we discuss key elements about data sharing in open repositories and we invite researchers around the world to deposit their data in them.


Author(s):  
Zuber D Mulla ◽  
Alok Dwivedi

ABSTRACT Introduction The benefi ts and uses of ultrasound (US) are well documented for procedural and diagnostic purposes. A number of studies have evaluated the utility of simulation-based US training in achieving competency and improving safety. To the best of our knowledge, no previous studies have attempted to synthesize the effectiveness of US simulation in Obstetrics and Gynecology (OB GYN) education using a systematic method. This review article summarizes the effect of US simulation on learning outcomes in OB GYN with three objectives: (1) To review and summarize the available evidence on the effectiveness of US simulation in OB GYN; (2) determine the validity and usefulness of US simulation in OB GYN training; and (3) describe advantages and disadvantages of various US simulators available in OB GYN as of 2016. Materials and methods We performed a literature search using different search engines, such as Medline PubMed and EMBACE using appropriate keywords. The data were extracted from all published eligible studies. A meta-analysis was conducted in order to obtain a pooled estimate of effect of US simulation in OB GYN education based on the availability of data on common outcomes. Results The majority of the included studies supported the usefulness or validity of simulation training in OB GYN for the enhancement of US skills. The US simulation signifi cantly improved the skills necessary to measure crown-rump length and nuchal translucency accurately. Conclusion Despite the cost, integration of US simulators in medical education appears to have a positive impact on the scanning and interpretation skills of trainees. This study may assist in preparing a dedicated curriculum for OB GYN US education via the inclusion of US simulation. How to cite this article Arya S, Dwivedi A, Mulla ZD, Kupesic Plavsic S. Effectiveness of Ultrasound Simulation in Obstetrics and Gynecology Education: A State-of-the-Art Review. Donald School J Ultrasound Obstet Gynecol 2017;11(2):115-125.


2019 ◽  
Vol 4 (12) ◽  
pp. 303
Author(s):  
Alyaa Afifah Abu Talib ◽  
Nor Rima Muhamad Ariff ◽  
Mohamad Sufian Hasim ◽  
Mohd Hafiz Hanafiah

Sustainability issues within the hotel industry are now increasingly known as a significant concern around the world. It has been described as a constituent activity that contributes to a significant impact on the environment. However, the concept of sustainable management is yet to be well received by the hotel industry in Malaysia. This paper aims to study the growing idea of Sustainable Facilities Management (SFM) adoption, specifically in the hotel industry. This paper provides valuable information on the theory of SFM evolution, including the meta-analysis on the SFM developing, trends and researchers around the world. This paper identified a total of 15 hospitality initiatives utilized around the globe, with only nine of them are currently employed and adopted by the hotel industry. These initiatives are essential that need to be implemented in a hotel organization to gain successful and holistic SFM practices adoption.Keywords: Sustainable; Sustainability Facilities Management (SFM); Hotel. eISSN: 2398-4287 © 2019. The Authors. Published for AMER ABRA cE-Bs by e-International Publishing House, Ltd., UK. This is an open-access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Peer–review under responsibility of AMER (Association of Malaysian Environment-Behaviour Researchers), ABRA (Association of Behavioural Researchers on Asians) and cE-Bs (Centre for Environment-Behaviour Studies), Faculty of Architecture, Planning & Surveying, Universiti Teknologi MARA, Malaysia.DOI: https://doi.org/10.21834/e-bpj.v4i12.1927


2020 ◽  
Vol 13 (41) ◽  
pp. 4297-4306
Author(s):  
Jerlin Priya Lovelin Auguskani ◽  

Background/Objectives: Corona virus disease 2019 (COVID-19) has been accepted as a pandemic by the World Health Organization in the month of March 2020. Globally many efforts have been made to inhibit the spread of the disease through various strategies to create public awareness and changing personal behaviors. According to WHO report as on 2nd of October 2020, the mortality was 34,079,542 and morbidity rate of 1,015,963. In Saudi Arabia, there are 335,578 positive cases of coronavirus, 4,823 deaths and 320,348 recovered from illness. Keeping this in view, the present study was conducted to understand the level of awareness, attitude and perception regarding prevention and control of COVID 19 among people of the Kingdom of Saudi Arabia. Methods: Quantitative research approach was adopted with Cross sectional descriptive research design. Data was collected through the online semi structured questionnaire. The questionnaire has four sections including demographic variable, awareness, attitude and perception. The analysis is based on 301 respondents from 13 regions of the Kingdom of Saudi Arabia. Descriptive statistics was used to analyze the data. Findings: COVID 19 outbreak threaten the life and wellbeing of people around the world. The study finding shows that the people of Kingdom of Saudi Arabia have adequate awareness in various component of corona virus with positive attitude and good practices with regard to disease spread. Also, majority of young people mentioned that they attained awareness from social media, whereas the other age group mentioned as MOH as the major source of information. Hence, constant public educational campaign with various sources have added advantage with present outcome. Novelty: While COVID 19 outbreak threaten the life and wellbeing of people around the world, it’s vital to constantly create awareness in cause, spread, treatment and prevention to control its impact further. Keywords: COVID 19; awareness; attitude; practice; Coronavirus


2019 ◽  
Author(s):  
Yoram Harth

UNSTRUCTURED The high cost and scarcity of physicians results in lack of proper service to the majority of the population in the US and more so in the rest of the world. Telehealth, based on remote physicians does not seem to be the solution due to less than optimal cost/benefit ratio offered to the human provider. Recent developments in mobile processing power, mobile camera resolution, and deep learning technology present an opportunity to build solutions to specific diseases that are comparable in accuracy to a human in-person service for a fraction of the cost democratizing the availability of health services.


2020 ◽  
Vol 38 (4_suppl) ◽  
pp. 810-810
Author(s):  
Gursharan Kaur Sohi ◽  
Jordan Levy ◽  
Victoria Delibasic ◽  
Laura Davis ◽  
Alyson Mahar ◽  
...  

810 Background: Cancer treatment is a significant driver of healthcare costs worldwide, however, the economic impact of treating patients with anti-neoplastic agents is poorly elucidated. Hence, we conducted a systematic review and meta-analysis to estimate the direct costs associated with administering intravenous chemotherapy in an outpatient setting. Methods: We systematically searched four databases from 2010 to present and extracted hourly administration costs and the respective components of each estimate. Separate analyses were conducted of Canadian and United States (US) studies, respectively, to address a priori hypotheses regarding heterogeneity amongst administration cost estimates. The Drummond checklist was used to assess risk-of-bias. Data were summarized using medians with interquartile ranges and five outliers were identified; costs were presented in 2019 USD. Results: A total of 44 studies were analyzed, including sub-analyses of 19 US and seven Canadian studies. 26/44 studies were of moderate or high quality. When components of administration cost were evaluated, physician costs were reported most frequently (24 studies), followed by lab tests (13) and overhead costs (9). The median cost estimate when outliers were excluded was $142/hour (IQR = $103-166). Sensitivity analyses determined the median administration cost in the US was $149/hour (IQR = $118-158), and was $128/hour (IQR = $102-137) in Canada. Conclusions: There is currently a paucity of literature addressing the costs of chemotherapy administration, and existing studies utilize a patchwork of reporting methodologies which renders direct comparison challenging. Our results demonstrate that the cost of administering chemotherapy is approximately $125-150/hour, globally. This value is dependent upon the region of analysis, inclusiveness of cost subcomponents as well as the methodology used to estimate unit prices, as described here.


2021 ◽  
pp. 228-234
Author(s):  
Niloy Sarkar ◽  
Bijoy Kumar Mandal ◽  
Soumya Paul

At present most of the world is at a standstill for the exponential increment of novel Corona virus outbreak. Novel Corona virus is one of the most dangerous viruses in the world. After extensive investigation, now it is clear that the onset of the current novel Corona virus started from Wuhan Seafood Market during December 2019, possibly from different zoonotic events. [1] Corona virus is actually a respiratory infection in humans, where the characteristics of Corona virus are similar with the characteristics of SARS-CoV. SARS-CoV originated in Guangdong, China, in the year 2002, a total of 8098 people were affected from the virus in 37 countries [2]. After that another Corona virus, namely the Middle East respiratory syndrome Corona virus (MERS-CoV) which was first identified in Saudi Arabia in the year 2012 [3]. At present the whole world is suffering for another Corona virus named 2019-novel Corona virus (2019n-CoV), which originated in Wuhan, China. Among SARS-CoV-2, MERS-CoV and 2019n-CoV there are many similarities. Whereas the novel Corona virus is transmitted from humans to another human, the SARS-CoV and MERS-CoV have found in animal body [4]. The necessary figures related to COVID-19 outbreak in all over the world is – Confirmed cases – 29,59,929, Confirmed deaths – 2, 02, 733 and Countries, areas or territories affected - 213 based on the WHO’s report of 28-April-2020. in order to defeat the COVID-19 we should gather more knowledge about this pandemic, hence in this paper we will discuss about various demerits and merits of novel Corona virus pandemic.


Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Lorenzo Pradelli ◽  
Stanislaw Klek ◽  
Konstantin Mayer ◽  
Abdul Jabbar Omar Alsaleh ◽  
Martin D. Rosenthal ◽  
...  

Abstract Background Omega-3 (ω-3) fatty acid (FA)-containing parenteral nutrition (PN) is associated with significant improvements in patient outcomes compared with standard PN regimens without ω-3 FA lipid emulsions. Here, we evaluate the impact of ω-3 FA-containing PN versus standard PN on clinical outcomes and costs in adult intensive care unit (ICU) patients using a meta-analysis and subsequent cost-effectiveness analysis from the perspective of a hospital operating in five European countries (France, Germany, Italy, Spain, UK) and the US. Methods We present a pharmacoeconomic simulation based on a systematic literature review with meta-analysis. Clinical outcomes and costs comparing ω-3 FA-containing PN with standard PN were evaluated in adult ICU patients eligible to receive PN covering at least 70% of their total energy requirements and in the subgroup of critically ill ICU patients (mean ICU stay > 48 h). The meta-analysis with the co-primary outcomes of infection rate and mortality rate was based on randomized controlled trial data retrieved via a systematic literature review; resulting efficacy data were subsequently employed in country-specific cost-effectiveness analyses. Results In adult ICU patients, ω-3 FA-containing PN versus standard PN was associated with significant reductions in the relative risk (RR) of infection (RR 0.62; 95% CI 0.45, 0.86; p = 0.004), hospital length of stay (HLOS) (− 3.05 days; 95% CI − 5.03, − 1.07; p = 0.003) and ICU length of stay (LOS) (− 1.89 days; 95% CI − 3.33, − 0.45; p = 0.01). In critically ill ICU patients, ω-3 FA-containing PN was associated with similar reductions in infection rates (RR 0.65; 95% CI 0.46, 0.94; p = 0.02), HLOS (− 3.98 days; 95% CI − 6.90, − 1.06; p = 0.008) and ICU LOS (− 2.14 days; 95% CI − 3.89, − 0.40; p = 0.02). Overall hospital episode costs were reduced in all six countries using ω-3 FA-containing PN compared to standard PN, ranging from €-3156 ± 1404 in Spain to €-9586 ± 4157 in the US. Conclusion These analyses demonstrate that ω-3 FA-containing PN is associated with statistically and clinically significant improvement in patient outcomes. Its use is also predicted to yield cost savings compared to standard PN, rendering ω-3 FA-containing PN an attractive cost-saving alternative across different health care systems. Study registration PROSPERO CRD42019129311.


2020 ◽  
pp. 001857872098543
Author(s):  
Monica L. Bianchini ◽  
Meghan N. Jeffres ◽  
Jonathan D. Campbell

Introduction: Carbapenem-resistant organisms (CROs) present a serious public health problem. Limited treatment options has led to increased use of colistin and polymyxin. Since 2014, the US Food and Drug Administration approved 4 new beta-lactam beta-lactamase inhibitor (BLBLI) combination antibiotics with activity against CROs. These new antibiotics have been shown to be more effective and less toxic than colistin and polymyxin but are considerably more expensive. This study evaluated the cost-effectiveness of the new BLBLIs versus colistin-based therapy for the treatment of CROs. Methods: A decision-tree microsimulation model was used to evaluate the cost effectiveness of the new BLBLIs versus colistin-based therapy for the treatment of CROs. Treatment groups differed in risk of mortality and risk of an acute kidney injury (AKI). The relative risk of mortality was determined by creating a meta-analysis comparing new BLBLIs to colistin. Cost inputs included medication costs and the cost to treat an AKI. The primary outcomes include quality-adjusted life years (QALYs) and incremental cost-effectiveness ratio (ICER). Model inputs included: clinical outcomes and adverse events (30-day mortality and AKI); cost of treatment and adverse drug events; and health utilities. A 3% discount was applied for outcomes. A lifetime horizon was used from the perspective of the US healthcare system with a willingness-to-pay (WTP) threshold of $100 000. A sensitivity analysis was done to incorporate uncertainty. Results: The meta-analysis found the treatment with a new BLBLI was associated with a 50% decrease in the relative risk of 30-day mortality compared to colistin (RR 0.47, 95% CI 0.25-0.88). Treatment with a new BLBLI cost $16 200 and produced 11.5 QALYs, on average. The average colistin based regimen cost $3500 and produced 8.3 QALYs. The new BLBLIs were determined to be cost-effective with an ICER of $3900 per QALY gained. Treatment with a BLBLI remained cost-effective under all uncertainty scenarios tested. Conclusion: New BLBLIs are cost-effective compared to colistin for the treatment of CROs and are associated with improved mortality and fewer AKI events. The use of colistin should be reserved for cases where new BLBLIs are not available or there is documented resistance to these new antibiotics.


Sign in / Sign up

Export Citation Format

Share Document